Efficacy of Zinc in the Treatment of Pneumonia

N/ACompletedNCT00198666

Johns Hopkins Bloomberg School of Public Health299 enrolled

Overview

This study is designed to evaluate the efficacy of zinc supplementation in the treatment of children under the age of two years who have been hospitalized with severe pneumonia.

This study was a randomized, double-blind, placebo-controlled clinical trial conducted between September 2003 and August 2004 at the Christian Medical College (CMC) Hospital in Vellore, India. CMC Hospital is a large teaching hospital and medical center that is accessed directly by the population of Vellore and adjoining districts and by referrals from local medical practitioners.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

299

Conditions

Pneumonia

Interventions

ZincDRUG

Elemental Zinc

Eligibility

Sex: ALLMax age: 23 Months

Medical Language ↔ Plain English

Inclusion Criteria: * children under two years old hospitalized with Pneumonia Exclusion Criteria: * healthy children

Outcomes

Primary Outcomes

Duration of severe symptoms

Time frame: 2 years

Secondary Outcomes

Time to recovery from severe pneumonia

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.